Standardization

Plant / Ingredient	Standardization	Dry plant qty per 7,5 ml
Rice germ	GABA 40%	1000 mg (germs)
Griffonia	5-HTP 5%	385 mg (fruits)
Ashwagandha	Withanolides 2%	335 mg (roots)
Suma	Saponides 2%	265 mg (roots)
Yuzu	Limonoids 0,2%	100 mg (roots)

Pharmacological activity

Recognized traditional use.

RICE GERM (Orytza Sativa) or GABA

Origin: Japan

• Relaxation properties;
• Reduction of anxiety and panic sensation;
• Concentration increase.

GRIFFONIA (Griffonia Simplicifolia)

Origin: Africa

• Mood improvement (serotonin precursor);
• Control of appetite;
• Improvement of the quality of sleep.

ASHWAGANDHA (Withania Somnifera)

Origin: India

• Adaptogene;
• Elimination of toxic substances in the nervous cells;
• Antioxidant.

SUMA (Pfaffia Paniculata)

Origin: Brazil

• Anti-stress;
• Energizing properties.

YUZU (Citrus junos)

Origin: Japan

• Relaxing properties;
• Helps memory and concentration.

• Prolonged use: To relieve daily stress symptoms, take 1½ teaspoon (7,5 ml) once daily. The effect is noticeable within minutes after ingestion.
• Punctual use: To relieve stress symptoms and increase concentration before a public performance, employment interview, exams, etc., dilute 1½ teaspoon (7,5 ml) in a small amount of water or juice. The effects will be noticeable within minutes after ingestion. Take a second dose if needed.
• Urgent use: To relieve panic attacks or intense stress, take 1½ teaspoon (7,5 ml) and keep under the tongue for a minimum of 30 seconds, then swallow. The effects should be felt within a few minutes. The benefit will increase after a few days.

• Are exposed to stressing living conditions (work, love life, etc);
• Are exposed to stressing events (public performance, employment interview, exams, etc.);
• Live with the after-effects of an old stress;
• Suffer from panic attacks.

CONTRAINDICATIONS

• Allergic to ingredients in the formulation;
• Avoid giving to children under 12 years of age and to pregnant or breastfeeding women without the advice of your health practitioner.

PRECAUTIONS

• o Avoid in serious diseases: hemophilia, ACV, trisomy, cancer, etc.;
• o Avoid in case of epilepsy.

DRUG INTERACTIONS

Relaximum

• May increase the effects of the following drugs: antiolytics (antidepressants), beta-blockers, ISRS;
• Interacts with MAOI, lithium, anti-anxiety drugs;
• No pharmaceutical product or natural product should be combined with anticoagulants without consulting a physician;
• In the event of serious illness or consumption of drugs, do not consume this product without the consent of your doctor or your healthcare professional.

SECONDARY EFFECTS

Relaximum: ingesting double the recommended dosage, rarely gives side effects.

• Consult a health practitioner if abdominal cramps, diarrhea or nausea appears;
• Certain individual may observe reactions similar to that of an allergic reaction. This reaction is similar to that seen with the hot flash felt during the use of niacin (B3 vitamin). Although this reaction seldom occurs, the effect will only last for a few minutes and is harmless. It may occur punctually, particularly when the person is tired or overworked. This reaction is absolutely WITHOUT DANGER.
• If embarrassing reactions appear after the first dose, the person may be very sensitive to the product. By decreasing the dose, the adverse effects disappear, leaving room for just beneficial effects.

SPEED OF EFFECT

• For use during a crisis: panic attacks, moments of distress, etc.; effects are felt in only 1 minute;

• For use in acute situations: stressing situations, death, divorce, traumatism, effects will be felt in 10-20 minutes;
• For long-term use: to relieve symptoms such as depression, insomnia, lack of concentration, effects can be felt within a few days to over 4 weeks.

SYNERGISTIC ACTION

The components of this formulation were selected due to their synergistic effect:

• Rice Germ and the fruits of griffonia are the suppliers of two intermediaries essential for cerebral circuits (GABA and 5-HTP) implied in the process of stress regulation. They act upon serotonin production “pleasure hormone”, and inhibit the harmful effects inducted by cortisol accumulation;
• Being adapting agents, the plants in our product exert multiple influences on brain chemistry. The substances contained in the plants provide the brain regulating factors that are necessary in the production of neurotransmitters:

• GABA neurotransmitter (in Rice Germ) and saponides (contained in suma) limit the accumulation of cortisol by inhibiting (blocking) several levels of operation (see 1);
• Griffonia, with its 5-HTP molecule, regularizes the production of serotonin which is responsible for pleasant moods;
• Withanolides of the ashwagandha have an anti-anxiety effect by “cleansing” the nervous cells (cellular antioxidants).

Together, these elements regulate the release of neurotransmitters and their balance in the brain. The synergistic action allows to increase low amounts of neurotransmitters in the brain such as serotonin and dopamine, and to decrease the amount of cortisol in the brain, if it is present in greater than normal quantities. Consequently, this formulation allows the brain to produce a homeostatic quantity of neurotransmitters and to regulate natural and biological production, without any long-term assistance.

Finally, the difference between this formulation and allopathic medication is that the formulation provides substances to the brain which will immediately regulate the problem without producing or halting the production of natural neurotransmitters. Unlike in the case of using allopathic medication where the brain becomes lazy and will cease working by itself since it needs external substances provided by the allopathic medication.

The antistress tonic rehabilitates the brain and allows it to produce an adequate amount of molecules while being stimulated and/or being calmed. Through this mechanism, the brain recovers, and is able to function on its own. Moreover, the side effects are tiny compared to those listed from the antidepressants.

Q. Does this product cause dependence like antidepressants do?

A. No. It acts in a natural way on the biological circuits of the brain, by giving it the ability to control itself.

• Cortisol: The "Stress Hormone" From Melissa C. Stöppler, M.D., Your Guide to Stress Management. Consulted September 13, 2005;
• http://compalim.darguere.com/compl/ashwagandha.htm « Les compléments alimentaires, Ashwagandha » updated October 2002;
• Ahmad, Muzamil; Saleem, Sofiyan; Ahmad, Abdullah Shafique; Ansari, Mubeen Ahmad; Yousuf, Seema; Hoda, Md Nasrul; Islam, Fakhrul Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats Human & Experimental Toxicology, Volume 24, Number 3, March 2005, pp. 137-147(11);
• Padmavathi B, Rath PC, Rao AR, Singh RP. Roots of Withania somnifera Inhibit Forestomach and Skin Carcinogenesis in Mice;
• Owais M, Sharad KS, Shehbaz A, Saleemuddin M. Antibacterial efficacy of Withania somnifera (ashwagandha) an indigenous medicinal plant against experimental murine salmonellosis Phytomedicine. 2005 MAR;12(3):229-35;
• Kneuritic Regeneration and Synaptic Reconstruction Induced by Withanolide A., Br J Pharmacol. 2005 apr; 144(7): 961-71; Magazine électronique «La lettre du psy », Volume 2, No. 8: Augustt 1998, HTTP://WWW.HERBAL-powers.com/ashwagandha1.html
• http://www.univers-nature.com/sante-nature/griffonia.html; Integrative Medicine Communications (Ed). Clinical reference, Herbs - 5-HTP, Onemedicine.com. [Consulted February 18, 2003]. www.onemedicine.com.
• Therapeutic Research Faculty (Ed). 5-HTP, Natural Medicines Comprehensive Database. www.naturaldatabase.com
• Duke JA. CRC Handbook of Medicinal Herbs. Boca Raton, FL: CRC Press, 1985, 514-5.
• Bone K. Clinical Applications of Ayurvedic and Chinese Herbs; Queensland, Australia: Phytotherapy Press, 1996, 137–41; Wagner H, Nörr H, Winterhoff H. Plant adaptogens. Phytomed 1994;1:63–76.
• Anabalgan K, Sadique J. Antiinflammatory activity of Withania somnifera. Indian J Exp Biol 1981;19:245–9.
• Bhattacharya SK, Kumar A, Ghosal S. Effects of glycowithanolides from Withania somnifera on an animal model of Alzheimer’s disease and perturbed central cholinergic markers of cognition in rats. Phytother Res 1995;9:110–3.
• Bone K. Clinical Applications of Ayurvedic and Chinese Herbs. Queensland, Australia: Phytotherapy Press, 1996, 137–41.
• Berry, Paul E., Bruce K. Holst, Kay Yatskievych, 1995. Flora of the Venezuelan Guayana, Missouri Botanical Garden.
• Gentry, Alwyn, H., 1993. A Feild Guide to the Families and Genera of Woody Plants of Northwest South America, University of Chicago Press, Chicago IL, Record number 0079-00504 Nova Genera et Species Plantarum 542 43. Pl. 140, 142. 1826.
• Schultes, R.E., and Raffauf, The Healing Forest. Medicinal and Toxic Plants of the Northwest Amazonia, R.F. Dioscorides Press, 1990.
• De Oliveira, Fernando., 1986. "Pfaffia paniculata (Martius) Kuntze - Brazilian ginseng." Rev. Bras. Farmacog. 1(1) 86-92
• Schwontkowski, Dr. Donna, 1993. HERBS OF THE AMAZON, Traditional and Common Uses, Science Student BrainTrust Publishin, Utah Hobbs, Christoper, 1996. "Adaptogens - Herbal Gems to Help Us Adapt." Let's Live Magazine. Anuario Naturista, 1992. Los Productos Naturales, 5th Ed., Mundo Naturista, Quito, Ecuador
• Bartram, Thomas. Encyclopedia of Herbal Medicine, 1995. Ed Grace Publishers, Dorset England
• Flynn, Rebecca & Roest, Mark., 1995 Your Guide to Standardized Herbal Products. One World Press.
• Prescott, AZ Lucas, Richard, M., 1991., Miracle Medicine Herbs, Parker Publishing, USA
• Heinerman, John, 1996. Heinerman's Encyclopedia of Healing Herbs & Spices. Parker Publishing Co. USA.
• Powerful and Unusual Herbs from the Amazon and China, 1993. The World Preservation Society, Inc.
• Balch J.F. & Balch, P.A., 1990, Prescription for Nutritional Healing. Avery Publishing Group, USA Dr. Donna Schwontkowski., 1994, 1995. "Herbal Treasures from the Amazon", A series of three articles published in Healthy & Natural Journal 1994, 1995.
• Nishimoto, N., et.al., 1988. Constituents of "Brazil ginseng" and some Pfaffia species. Tennen Yuki Kagobutsu Toronkai Keon Yoshishu 10, 17-24 (Japan)
• Nishimoto, N., et.al., 1988. Three ecdysteroid glycosides from Pfaffia. Phytochemistry, 27(6), 1665-8
• Beta-Ecdysone from Pfaffia paniculata, Japanese patent number (84 10,600) Jan. 20, 1984 by Wakunaga Pharmaceutical Co., Ltd.
• De Oliveira, F.G., et.al., Contribution to the pharmacognostic study of Brazilian ginseng Pfaffia paniculata, An. Farm. Chim. 20(1-2)m 361-277 (1980), 261.
• Nakai, Shiro, et.al., 1984., Pfaffosides. Part 2. Pfaffosides, nortriterpenoid saponins from Pfaffia paniculata. Phytochemisty 1984, 23(8). 17-3-5
• Nishimoto, N. et.al. 1984., Pfaffosides and nortriterpenoid saponins from Pfaffia paniculata., Phytochemistry 1984., 23(1), 139-42.
• Takemoto, T., et.al., 1983. Pfaffic acid, a novel nortriterpene from Pfaffia paniculata Kuntze., Tetrahedron Lett. 1983, 24(10), 1057-60
• Bruneton, Jean. 1995., Pharmacognosy, Phytochemistry, Medicinal Plants. Intercept Ltd., Hampshire England
• Antitumor pfaffosides from Brazilian carrots. Japanese Patent Number (84 184,198) Oct. 19, 1984 by Rohto Pharmaceutical Co., Ltd.
• Pfaffic acid and its derivatives., Japanese Patent Number (84 10,548) Jan 20, 1984 by Rohto Pharmaceutical Co., Ltd.
• Araujo; Joao T. Brazilian ginseng derivatives for treatment of sickle cell symptomatology U.S. Patent #5,449,516 Sept. 12, 1995
• Meybeck , et al., Use of an ecdysteroid for the preparation of cosmetic or dermatological compositions intended, in particular, for strengthening the water barrier function of the skin or for the preparation of a skin cell culture medium, as well as to the compositions U.S. Patent 5,609,873 March 11, 1997
• Meybeck , et al., Hydrated lipidic lamellar phases or liposomes based on ecdysteroids U.S Patent 5,198,225 March 30, 1993
• Watanabe T, Effects of oral administration of Pfaffia paniculata (Brazilian ginseng) on incidence of spontaneous leukemia in AKR/J mice. Cancer Detect Prev. 2000; 24(2):173-8.
• Goodman and Gilman’s, the pharmacological basic of therapeutics, seventh edition, 1985, Amino-acid P.247-250; 487.
• http://ift.confex.com/ift/2004/techprogram/paper_22641.htm, Effect of antioxidant flavanone, naringenin, from Citrus junos on neuroprotection.
• Hume, H.H. 1957. Citrus fruits. The Macmillan Co. New York. pp. 390 – 395.

Combinations of products suggested for individuals suffering from the following problems:

• People exposed to stressful living conditions or briefly exposed to an extremely stressful event or suffering from panic attacks, should combine Relaximum with B-Balance. Vitamins from Complex B are known as “Stress Vitamins.” The majority of stressed individuals suffer from this vitamin deficiency. A deficiency may cause tiredness, irritability, a predisposition to infections such as the common cold or influenza. Often, their consumption will result in a feeling of wellbeing and energy.

• Individuals suffering from depression, demotivation, extreme sensitivity and nervousness, anguish, sadness, discomfort, social isolation, such as cooperation difficulties, constant inward looking,  etc., should combine Relaximum with Neurotonik. This combination allows for a regulation of neurotransmitters: serotonin, dopamine, etc, implicated in these types of problems. By combining these two products, the unpleasant symptoms and the major underlying cause will be solved at the same time. B-Balance may also allow to find energy, and to eliminate deficiencies as a potential source of the problem.

• Insomniacs or individuals suffering from sleep disorders should combine this product with Somny Z. Somny Z will act on the neurotransmitters and the physiologic mechanisms supporting sleep. Relaximum acts on the source of the problem: stress which is often causing insomnia. Relaximum is not a product which helps sleep; but by reducing the level of stress significantly, it produces sleep for the individual suffering from insomnia caused by stress.

• Individuals with migraines should combine this product with Aurorus. It acts on symptoms and the frequency of the migraines. Relaximum acts on the potential source of the migraine.

• Nicotinic weaning or other drugs. This product helps to regulate symptoms associated with addiction or the feelings of “lack.” i.e. withdrawal symptoms. Often, when ceasing the consumption of a drug, symptoms of anxiety, fever, and need for the eliminated substance occurs. Relaximum helps to mitigate these unpleasant effects of weaning. Depending on the symptoms, during the first month, the patient should use Neurotonik, in order to reduce the risk of relapse, and to help to re-balance neurotransmitters. This product could also be combined with D-Toxi in order to re-balance neurotransmitters. This product could also be combined with D-Toxi, in order to eliminate harmful drug residues, and accelerate their evacuation from the system. AntiOxy Bio is also suggested, as well as Metabotonik, if the patient compensates his symptoms by eating too much.

• Modifications of food habits: bulimia (exaggeration of appetite); anorexia (loss of appetite), Metabotonik is strongly suggested. It reduces feelings of hunger, sugar cravings, and absorption of lipids. The use of a multi-vitamin such as Vita Balance for Man ♂ or Woman ♀, would also be desirable in order to eliminate food deficiencies that may be the main source of the problem.

• Concentration disturbances necessary to perform tasks, lapses of memory, a decrease in school performance or work output, etc. Focus is adapted perfectly to treat these types of problems. By reducing stress and increasing concentration, the performance of the individual will improve very quickly.

• The individual suffering from breathlessness, pulmonary oppression, arrhythmia, palpitations, etc, should undergo cardiac evaluation in order to eliminate the possibilities of cardiac or pulmonary disorders.